Boehringer inhalers now available at $35 a month for eligible patients Boehringer inhalers now available at $35 a month for eligible patients Boehringer COPD and asthma inhalers now available at $35 a month for eligible patients
U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes
US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes